Johnson & Johnson Launches 'Gut Tunnel' Experience in Singapore to Highlight the Importance of Endoscopic Remission in IBD
May 18, 2026
Singapore, May 18: Ahead of World IBD Day, Johnson & Johnson today launched the interactive 'Gut Tunnel' experience in Singapore, alongside educational programs across Asia Pacific, to empower people living with inflammatory bowel disease (IBD) to pursue endoscopic remission, a critical yet under-recognized treatment goal, as part of its ongoing Dual Control campaign. New data presented at Digestive Disease Week 2026 reinforces endoscopic remission as being associated with long-term patient outcomes, [1], [2] yet more than 60% of people with IBD have not heard of this key treatment goal. [3], [4] Anchoring World IBD Day, the interactive Gut Tunnel installation (18-21 May, Asia Square 2, Singapore) makes invisible inflammation and deeper gut-level control easier to understand.
